Mitochondrial function can play significant part in serious disease
- Details
- Published on 03 May 2021

Disorders of the cells' energy supply can cause a number of serious diseases, but also seem to be connected to ageing. More research is needed on mitochondrial function to find future treatments. A new study involving researchers at Karolinska Institutet shows how an important molecule inside the mitochondria affects their function in mice and fruit flies. The study, which is published in Science Advances, adds valuable knowledge on formerly relatively unexplored protein modifications.
In each cell of the body is an organ called the mitochondrion, which converts nutrients in our food to energy. Mitochondria are an essential part of the metabolism, and when things go wrong we can develop serious diseases.
Mitochondrial dysfunction is the hallmark of a group of rare genetic disorders but can also be observed in common diseases such as diabetes, heart disease, neurodegenerative diseases and the normal ageing process.
More research is needed on mitochondria and how they communicate with the rest of the cell if scientists are to find new therapeutic approaches to improve mitochondrial function.
Researchers at Karolinska Institutet, the Max-Planck Institute for Biology of Ageing in Cologne and the University of California San Diego have now studied how the methylation of proteins affects different mitochondrial processes.
Methylation is a chemical modification in which a methyl group (CH3) is added to a molecule, thereby potentially affecting its function. S-Adenosylmethionine (SAM), also known as AdoMet, is the main methyl group donor within the cell, including inside of mitochondria.
"We're interested in studying this particular molecule since the production of SAM changes in cancer and when we age," says Anna Wredenberg, researcher at the Department of Medical Biochemistry and Biophysics, Karolinska Institutet.
By completely removing SAM from the mitochondria of fruit flies and mice, the researchers have been able to study which processes in the mitochondria are dependent on methylation.
"Earlier studies have shown that both SAM and cellular energy levels drop during ageing. Our study suggests a link between these two pathways by demonstrating that low SAM levels can influence mitochondrial energy production."
The study has identified which of the mitochondrial proteins are methylated and how methylation affects them, and how these modifications might affect mitochondrial function. The researchers also demonstrate the physiological consequences of the lack of such changes. However, several questions still need answering.
"Our study has provided an indication that some modifications can be modulated by diet, but we need to continue examining if we can change the pathological process for the better," says Anna Wredenberg. "So far we've only looked at protein changes, but other molecules can also be modified by intra-mitochondrial SAM. We have to study these modifications to get a better understanding of the role it plays."
The study was financed by the Swedish Research Council, the European Research Council, the Knut and Alice Wallenberg Foundation, the Max Planck Society and the Ragnar Söderberg Foundation. There are no reported conflicts of interest.
News Source: https://www.sciencedaily.com/releases/2021/02/210219155928.htm
Florian A. Schober, David Moore, Ilian Atanassov, Marco F. Moedas, Paula Clemente, Ákos Végvári, Najla El Fissi, Roberta Filograna, Anna-Lena Bucher, Yvonne Hinze, Matthew The, Erik Hedman, Ekaterina Chernogubova, Arjana Begzati, Rolf Wibom, Mohit Jain, Roland Nilsson, Lukas Käll, Anna Wedell, Christoph Freyer, Anna Wredenberg. The one-carbon pool controls mitochondrial energy metabolism via complex I and iron-sulfur clusters. Science Advances, 2021; 7 (8): eabf0717 DOI: 10.1126/sciadv.abf0717
Mitochondrial dysfunction caused by bacteria activates intrinsic apoptosis and inflammation
- Details
- Published on 20 August 2020

Monash Biomedicine Discovery Institute (BDI) scientists have discovered a previously unknown method used by bacteria to evade immune responses.
The study, published in Nature Microbiology, points to potential new ways of countering bacterial infections, which are becoming increasingly resistant to antibiotics.First author Dr Pankaj Deo said researchers in Dr Thomas Naderer’s laboratory took a different approach to understanding the process by which bacteria release toxins that disarm the “powerhouse” mitochondria in immune cells.The study showed that immune cells sense that their mitochondria are no longer functional during infections, which triggers apoptosis. “Ironically, it is the activation of host cell death factors that deliver the final blow to mitochondria which induces apoptosis, not the bacterial toxins themselves,” Dr Pankaj said.The researchers genetically targeted apoptotic factors and showed that they were able to reduce inflammation in mice, which increased health outcomes.They used the bacterial pathogens Neisseria gonorrhoeae, uropathogenic Escherichia coli and the deadly Pseudomonas aeruginosa, prevalent in hospitals and which can be multi-drug resistant. However, the findings would apply to other species of bacteria too, Dr Deo said.Dr Naderer, who oversaw the research, said that understanding the ways some bacterial infections evade immune response by targeting mitochondria opens new therapeutic possibilities.“There’s been a lot of effort trying to block endotoxins that kill immune cells but this study really shifts the focus onto different toxins that might be more important,” Dr Naderer said.“It gives us a few good leads that we can look at as a next step,” he said.“We’ve shown in this paper that we can accelerate the immune response,” he said. “The other side is that if that response persists and we get constant inflammation – which is usually associated with bacterial infection and which causes a lot of tissue damage – we have a new way to shut down that tissue-damaging inflammation.”“What scientists have thought before is that when endotoxins are released by bacteria they induce an inflammatory type of programmed cell death called pyroptosis in immune cells,” Dr Deo said. Endotoxins are part of the external cell wall of essentially all Gram-negative bacteria.“We’ve found that the pathogenic bacteria use a similar mechanism to release additional toxins,” he said. “They kill immune cells by releasing small surface structures called outer membrane vesicles – packages of toxins that target mitochondria. The mitochondria are disarmed, become dysfunctional then die according to apoptosis or cellular suicide.”The scientists will investigate drugs that are now advancing to the clinic, and at repurposing drugs already in use, perhaps as anti-cancer treatments, to see if they can be used to clear bacterial infections.
News source: www.technologynetworks.com
Article: Deo et al. (2020). Mitochondrial dysfunction caused by outer membrane vesicles from Gram-negative bacteria activates intrinsic apoptosis and inflammation. Nature Microbiology. DOI: https://doi.org/10.1038/s41564-020-0773-2
Lack of mitochondria causes severe disease in children
- Details
- Published on 10 July 2020

The absence of FBXL4 leads to degradation of mitochondria that results in decreased ATP (energy) production and mitochondrial disease. Credit : news.ki.se
Researchers at Karolinska Institutet have discovered that excessive degradation of the power plants of our cells plays an important role in the onset of mitochondrial disease in children. These inherited metabolic disorders can have severe consequences such as brain dysfunction and neurological impairment. The study is published in EMBO Molecular Medicine.
“This is a completely new disease mechanism for mitochondrial disease which may provide a novel entry point for treating affected patients,” says Nils-Göran Larsson, professor at the Department of Medical Biochemistry and Biophysics, Karolinska Institutet, who led the study.
Mitochondrial diseases are inherited metabolic disorders that affect about 1 in 4,300 individuals and are caused by dysfunctional mitochondria. Mitochondria are the power plants of our cells and are crucial for converting energy derived from our food into the energy currency that drives the cell’s biochemical functions. Not surprisingly, organs that are mainly affected in patients are those with a high energy demand, such as the brain, heart, skeletal muscles, eyes and ears. In children, severe multisystem involvement and neurodegeneration are frequent manifestations.
Severe consequences
FBXL4 is a gene that is implicated in controlling mitochondrial function, and mutations in this gene are one of the most common causes of mitochondrial diseases. FBXL4 mutations have been linked to encephalopathy, a form of brain dysfunction causing neurological impairment. The manifestations are impaired cognitive function, developmental regression, epileptic seizures and other types of neurological deficits. Despite the severe consequences of FBXL4 mutations in humans, the function of the protein that FBXL4 codes for has remained poorly understood.
In the current study, researchers generated mice that lack FBXL4 and showed that these mice recapitulate important characteristics present in patients with FBXL4 mutations. They were able to demonstrate that the reduced mitochondrial function is caused by increased degradation of mitochondria via a process called autophagy.
Too few mitochondria in the tissues
In the absence of FBXL4, mitochondria are more frequently delivered to the lysosome, the recycling station of the cell that contains enzymes that break down organic compounds. FBXL4 thus acts as a break on mitochondrial degradation. Patients who lack FBXL4 have too few mitochondria in their tissues which leads to disease.
“Further studies are needed to explore the therapeutic potential of these findings, in particular whether inhibition of the degradation of mitochondria may provide a new treatment strategy,” says Nils-Göran Larsson.
The study was financed by several bodies, including the Swedish Research Council, the Knut and Alice Wallenberg Foundation, the European Research Council, the Swedish Cancer Society, and the ALF agreement between the Swedish government and the regional councils.
News source : https://news.ki.se/lack-of-mitochondria-causes-severe-disease-in-children
Authors : David Alsina, Oleksandr Lytovchenko, Aleksandra Schab, Ilian Atanassov, Florian A Schober, Min Jiang, Camilla Koolmeister, Anna Wedell, Robert W Taylor, Anna Wredenberg, Nils‐Göran Larsson
EMBO Mol Med (2020) 12: e11659https://doi.org/10.15252/emmm.201911659
Who attended the Targeting Mitochondria 2020?
- Details
- Published on 23 July 2020
| Academia Sinica AgResearch, a Crown Research Insitute Ajou University Amsterdam UMC, VUmc Angers University Hospital Center APC Microbiome Augusta University Augusta University/College of Dental Medicine BASF SE Beiersdorf AG Benemérita Universidad Autónoma de Puebla Biochemia Zdrowia Krzysztof Michalak Biomedical Research Foundation of the Academy of Athens Brown University Bucheon St. Mary's hospital Center For Neuroscience And Cell Biology Center of Experimental Medicine SAS Champalimaud Foundation Children's Hospital of Philadelphia Christian Albrechts University Kiel Chubu University CHUV-Unil CiRA, Kyoto University Cleveland Clinic Lerner Research Institute CNC - Center for Neuroscience and Cell Biology College of Health Professions Comenius University in Bratislava Defence Institute of Physiology and Allied Sciences Department of Neurology, Otto-von-Guericke-University, Magdeburg, Germany Dept Toxicogenomics, School for Mental Health and Neuroscience /Maastricht University EA Pharma Co., Ltd. Emory University EPFL Epirium Bio Etablissement Français du Sang Nouvelle Aquitaine ETH Zurich Facultad de Medicina Universidad Autonoma de Nuevo Leon FRC Kazan Scientific Center FRC Kazan Scientific Center of RAS FUNDACIÓN INVESTIGACIÓN BIOMÉDICA HOSPITAL 12 DE OCTUBRE FUNDACIÓN PROFESOR NOVOA SANTOS Georg-August-Universität Göttingen German Cancer Research Center (DKFZ) Göteborgs Universitet Gothenburg University Hadassah-Hebrew University Medical Center Hannover Medical School Harvard Medical School Harvard University Hebrew University of Jerusalem Heidelberg University Hospital/Department of Anesthesiology HHMI Hokkaido Institute for Pharmacy Benefit Co.,Ltd. ICGEB IDIBAPS (INSTITUT D´INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER) Ifremer Imperial College INCYTON GmbH Indiana University Pathology & Laboratory Medicine INRAE, AgroParisTech INSERM DRTLS INSERM U1232 CRCINA Institut D'investigacions Biomèdiques August Pi i Sunyer Institute Cochin Instituto de Investigación Hospital 12 de Octubre (i+12) Instituto Politécnico Nacional Internistische Praxis Dr. Hendricks IVIRMA Jagiellonian University Janssen R&D JAWAHARLAL NEHRU UNIVERSITY John Hunter Hospital Johns Hopkins School of Medicine Jozef Stefan Institute Karolinska Institutet Kent State University Kirin Holdigns Company Ltd. Konyang University Korea Brain Research Institute Kyungpook National University Hospital l'aquila/Department of Life, Health and Environmental Sciences Leibniz Institute on Aging Lions Eye Institute Lithuanian University of Health Sciences London School of Hygiene and Tropical Medicine Lunds Universitet Maastricht university Maine Medical Center Research Institute Massachusetts General Hospital Mayo Clinic Medical College of Wisconsin Medical Faculty of Heidelberg University Medical University Innsbruck Medizinische Universität Innsbruck Merrimack College Midwestern University MitoVasc Institute MitoVasc Institute, Angers University Hospital Center MITOVASC Mitolab / University of Angers MMCRI Moffitt Cancer Center Montpellier Cancer Research Institute Nagoya Univ Nagoya University Nanna Therapeutics Nastaran, University of Iowa National Heart, Lung, and Blood Institute National Institutes of Health National Neuroscience Institute Netherlands Institute for Neuroscience Neurology Research |
NIH/NINDS/SCN |
Mitochondrial RNA degradation is essential for life
- Details
- Published on 10 July 2020

Credit : pubmed
Researchers at Karolinska Institutet have discovered the essential role of the ribonuclease REXO2 in mitochondrial RNA degradation. The enzyme is essential for life, as a deficiency of it in mice has shown to be embryonic lethal. The study is published in the journal Molecular Cell.
We have asked two of the lead authors, Henrik Spåhr and Shan Jiang from the Nils-Göran Larsson group at the Department of Medical Biochemistry and Biophysics, about the most important results from their study.
“The mitochondria are the power plants of our cells and are essential for converting the energy in the food we eat to a useful cellular energy currency. Importantly, mitochondria contain their own genetic material, mitochondrial DNA (mtDNA). MtDNA is totally distinct from the majority of our genetic material that is located in the nucleus. Expression of mtDNA is essential for the energy conversion of the cell, and the first step is to copy (transcribe) mtDNA to mitochondrial RNA, which, in turn, is the template for making 13 proteins that all are critically important for the cellular energy conversion. Quite a bit is known about how mitochondrial RNA is formed, but critical steps in the degradation have remained unknown. In the present study, we have identified an enzyme that is required for the last step of RNA degradation in human mitochondria, called REXO2”, Henrik Spåhr explains.
“This enzyme selectively degrades nanoRNAs (dinucleotides) and it is essential for life, as REXO2 deficiency results in embryonic lethality in mice.”
News source : www.news.ki.se
Authors : Nicholls TJ, Spåhr H, Jiang S, et al. Dinucleotide Degradation by REXO2 Maintains Promoter Specificity in Mammalian Mitochondria. Mol Cell. 2019;76(5):784-796.e6. doi:10.1016/j.molcel.2019.09.010
More Articles...
- Enhanced axonal response of mitochondria to demyelination offers neuroprotection: implications for multiple sclerosis
- The mitochondrial derived peptide humanin is a regulator of lifespan and healthspan
- One-time treatment generates new neurons, eliminates Parkinson's disease in mice
- Unexpected insights into the dynamic structure of mitochondria


























































